MedTrace Logo

The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control

NCT05478356 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-07-28

No results posted yet for this study

Summary

Both orthokeratology and atropine eye drops are effective methods for myopia control, but few studies have compared them all together simultaneously. Therefore, the primary aim of the present study was to compare the effect of orthokeratology versus low-dose (0.01% and 0.02%) atropine on the control of myopia progression.

Conditions

  • Myopia

Interventions

DRUG

low-dose atropine eye drops

low-dose atropine eye drops

DEVICE

orthokeratology

orthokeratology, ortho-K lenses

Sponsors & Collaborators

  • Evidence Based Cataract Study Group

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05478356 on ClinicalTrials.gov